- Details
- Description
Packaging Size:
30 capsules
Strength:
40 mg
Composition:
Selpercatinib INN
Treatment:
Anti-Cancer / Oncology
Form:
Capsule
Brand:
SELPACTA
Quantity Unit:
Capsules
Manufacturer:
Ziska Pharmaceuticals Limited
SELPACTA (Selpercatinib INN) is an oral targeted anti-cancer medicine containing selpercatinib, a selective RET kinase inhibitor that blocks abnormal RET signaling involved in cancer cell growth and progression. It is used for certain RET fusion-positive or RET mutation-positive cancers, including specific cases of non-small cell lung cancer and thyroid cancer. SELPACTA is listed as an anti-cancer medicine and is supplied in a 30-capsule pack.
